Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Imagine being one of the millions of Americans in need of a hip or knee replacement due to osteoarthritis. Severe pain, ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

CEO Will Johnson wrote, finding Harris data that (60%) of Gen Z spend at least four hours a day scrolling, with an equal number citing the negative impacts of social media on society (60% v. positive: ...

"This is an area in which we haven't had something we felt hopeful about in a while," professor Joseph Schacht said.

My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...

With the soaring popularity of drugs like Ozempic, the market is ripe for disruption,” researcher Rubina Aktar said.

QUESTION: I just opened a sealed bottle of bupropion XL 300 milligrams. It appears that this product was manufactured in ...

It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable ...